Insider Cluster (2 insiders) ·Filed Jun 3, 2026

EXEL

EXELIXIS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $2.7M total
Actionable Insight • Neutral

This cluster is too small to warrant a trading signal. Monitor for any C-suite open-market sales exceeding 0.1% of market cap, which would carry more weight. The next catalyst is likely the Q2 2026 earnings release.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
EXEL ▲ +3.84% at T+60d
NEUTRAL call ✓ call won +3.84% · α vs SPY +2.22% · entry $52.39 → $54.40
Entry anchored
Jun 3, 2026
via day open
T+1d
+0.57%
call +0.57% · α +3.17%
$52.69
settled 4mo ago
T+5d
+2.12%
call +2.12% · α +4.68%
$53.50
settled 4mo ago
T+20d
+6.61%
call +6.61% · α +8.23%
$55.85
settled 3mo ago
T+60d
+3.84%
call +3.84% · α +2.22%
$54.40
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Two Exelixis directors sold a total of ~$690K in open-market transactions over a 7-day window, representing ~0.006% of the company's $12.2B market cap. The dollar value is trivial relative to company size, and the trades lack C-suite participation, making this a routine cluster with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$690.0K
Insiders
2

Key Facts

  • Two directors sold a combined 13,737 shares for ~$690K in open-market transactions.
  • Total cluster value is ~0.006% of Exelixis' $12.2B market cap.
  • No C-suite executives (CEO, CFO, etc.) participated in the cluster.
  • The cluster includes no open-market purchases — all transactions are sales.

Financial Impact

~$690K in total insider sales, immaterial relative to $12.2B market cap.

insider holdings

Risk Factors

  • Insider sales could accelerate if upcoming earnings disappoint, but current volume is negligible.
  • No immediate risk from this cluster given the trivial dollar amounts.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EXEL-1780527146591
12 reports for EXEL
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +21.97%Feb 28, 2026
Filters
Rows
Reports for EXEL — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
8-K
BEARISH ★ 6/10
$56.12 $58.36▼ −3.99%▼ −4.21%$58.38 (−4.03%)
Aug 10, 2026
7w ago
Press Release
BEARISH ★ 7/10
$51.33 $53.10▼ −3.44%▼ −3.85%$58.38 (−13.73%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $53.50▲ +2.12%▲ +4.68%$58.38 (+11.44%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$50.20 $52.70▲ +4.98%▲ +7.73%$58.38 (+16.30%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.38 (+16.02%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.38 (+16.02%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $52.69▲ +4.71%▲ +7.23%$58.38 (+16.02%)
May 22, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $48.49▼ −2.90%▼ −4.12%$58.38 (+16.90%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $51.46▲ +3.15%▲ +1.34%$58.38 (+17.02%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $51.29▲ +11.26%▲ +9.76%$58.38 (+26.64%)
Showing 10 of 12

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 3, 2026